Clinical Trial Update: Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B)

View source ↗

Summary

This update summarizes results from a completed clinical trial (SAIL-B) evaluating characterization and clinical outcomes of severe asthma patients in Israel tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Asthma | Status: COMPLETED